Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Eur J Cancer. 2020 Oct 5;140:11–18. doi: 10.1016/j.ejca.2020.08.029

Table 3.

Multivariate analysis with Cox proportional hazard model for three survival endpoints: RFS, DMFS and MSS.

RFS DMFS MSS
Cohorts Predictors Hazard ratio (HR) P-value Hazard ratio (HR) P-value Hazard ratio (HR) P-value
Entire Cohort (n=831, excluded n=6) (Events: RFS: 164 ; DMFS: 110; MSS: 48) Breslow thickness 1.20 (1.12 – 1.29) <0.001 1.11 (1.03 – 1.19) 0.014 1.17 (1.07 – 1.28) 0.009
Age 1.02 (1.00 – 1.03) 0.004 1.01 (1.00 – 1.02) 0.156 1.02 (1.00 – 1.04) 0.072
Ulceration 1.56 (1.12 – 2.18) 0.010 1.71 (1.14 – 2.57) 0.011 1.64 (0.88 – 3.06) 0.125
SLNb status 2.28 (1.61 – 3.24) <0.001 2.10 (1.37 – 3.22) 0.001 1.74 (0.90 – 3.36) 0.102
CP-GEP risk labels 2.40 (1.53 – 3.74) <0.001 2.32 (1.35 – 3.97) 0.001 2.05 (0.93 – 4.54) 0.064
SLNb negative (n=633, excluded n=4) (Events: RFS: 89; DMFS: 59; MSS: 27) Breslow thickness 1.31 (1.13 – 1.52) 0.002 1.39 (1.16 – 1.66) 0.002 1.53 (1.12 – 2.08) 0.018
Age 1.01 (0.99 – 1.02) 0.220 1.00 (0.98 – 1.02) 0.752 1.03 (1.00 – 1.06) 0.073
Ulceration 1.45 (0.90 – 2.34) 0.131 1.33 (0.74 – 2.41) 0.349 1.52 (0.65 – 3.53) 0.345
CP-GEP risk labels 2.57 (1.53 – 4.34) <0.001 2.72 (1.40 – 5.28) 0.002 1.98 (0.76 – 5.16) 0.152
Stages I-IIA (n=578, excluded n=2) (Events: RFS: 68; DMFS: 47; MSS: 21) Breslow thickness 1.47 (1.07 – 2.02) 0.021 1.63 (1.13 – 2.37) 0.013 1.23 (0.67 – 2.27) 0.516
Age 1.01 (0.99 – 1.03) 0.272 1.00 (0.98 – 1.02) 0.642 1.03 (1.00 – 1.06) 0.069
Ulceration 0.95 (0.44 – 2.05) 0.900 1.15 (0.47 – 2.80) 0.765 1.20 (0.34 – 4.25) 0.783
CP-GEP risk labels 2.27 (1.25 – 4.12) 0.006 2.29 (1.09 – 4.77) 0.025 2.27 (0.79 – 6.51) 0.123